Noncorrectable vision problems associated with shorter lifespan in older adultsOctober 13, 2009Visual problems that cannot be corrected are associated with increased risk of death among individuals between the ages of 49 and 74, and all visual impairments may be associated with the risk of death in older adults, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Visual impairment has been associated with a higher risk of death as well as factors that may lead to increased death such as unintentional injury, depression, lower body mass index (BMI), reduced walking speeds, increased risk of falls, self-reported difficulty in physical activity, cardiovascular disease, dementia and cancer, according to background information in the article. "Correction for these 'confounders' has been found to attenuate the association between visual impairment and mortality, but the mechanisms behind the association between visual impairment and mortality remain to be determined." Michael J. Karpa, M.B.B.S., B.Sc., of Westmead Millennium Institute, Sydney, Australia, and colleagues used data from the Blue Mountains Eye Study, which examined visual impairment in 3,654 participants age 49 and older between 1992 and 1994 and after five and ten years, to evaluate the relationship between visual impairment and death risk among older individuals. At baseline, participants with noncorrectable visual impairment were more likely to be female, age 75 and older and underweight. Those with correctable visual impairment were more likely to be age 75 and older, but had no difference in proportions of women or BMI. Thirteen years after baseline, 1,273 participants had died. A higher risk of dying was associated with noncorrectable visual impairment, with a stronger association for participants younger than age 75. The analyses "revealed greater effects of noncorrectable visual impairment on mortality risk, with both direct and indirect effects," the authors write. "Of mortality risk markers examined, only disability in walking demonstrated a significant indirect pathway for the link between visual impairment and mortality." "In conclusion, this study reaffirms that visual impairment is associated with an increased risk of all-cause mortality," the authors write. "Disability in walking may represent an important indirect pathway to mortality for persons with visual impairment, and adjusting for this factor in statistical analysis may overadjust for the indirect effect of visual impairment on mortality risk. The impact of visual impairment on mortality may in fact be greater than that reported from previous studies that have used traditional statistical models." JAMA and Archives Journals |
|||||||||||||||||||||
| Related Visual Impairment Current Events and Visual Impairment News Articles Sight gone, but not necessarily lost? Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. More infants surviving pre-term births results in higher rates of eye problems As more extremely pre-term infants survive in Sweden, an increasing number of babies are experiencing vision problems caused by abnormalities involving the retina. Study predicts 40 percent increase in blindness in Nigeria by 2020 By 2020, 1.4 million Nigerians over age 40 will lose their sight, and the vast majority of the causes are either preventable or treatable, according to the Nigeria National Blindness and Visual Impairment Study Group. South Asians with diabetes more likely to lose their eyesight earlier than White Europeans South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition. Researchers describe protease inhibitor that may aid in diabetic retinopathy treatment Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes. Conference report highlights new research into drug delivery to treat eye disease Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference. Vision loss more common in people with diabetes Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Role identified for glaucoma gene and related signaling pathway Researchers have found that a gene and a related signaling pathway play a role in the development of glaucoma, which is a common cause of visual impairment and blindness worldwide. USC study -- largest of its kind -- finds older children more likely to develop vision disorders In a study of more than 6,000 Los Angeles-area children - the largest study of its kind - researchers at the Keck School of Medicine of the University of Southern California (USC) found that both strabismus (commonly known as cross-eyed or wall-eyed) and amblyopia (often referred to as lazy eye) were more prevalent in older children than in younger children. Simple eye scan opens window to multiple sclerosis A five-minute eye exam might prove to be an inexpensive and effective way to gauge and track the debilitating neurological disease multiple sclerosis, potentially complementing costly magnetic resonance imaging to detect brain shrinkage - a characteristic of the disease's progression. More Visual Impairment Current Events and Visual Impairment News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||